Scopus BioPharma (Nasdaq: SCPS)
@ScopusSCPS
Transformational Immuno-Oncology Gene Therapy for Cancer Treatment
加入 December 2020
13 正在關注 162 粉絲
Scopus BioPharma (Nasdaq: $SCPS) is pleased to announce the FDA approval of the IND application for the company’s lead drug candidate - a distinctive RNA therapy and immunotherapy.
Read more here:
顯示更多
